Roche poised for deal to get back into antibiotics: paper

an image of the Roche logo(Reuters) – Swiss drugmaker Roche is poised to get back into antibiotics by taking over a candidate drug being developed by privately-owned Polyphor, the NZZ am Sonntag paper said on Sunday, without citing a source for the information.

The paper did not give any details of the transaction, but said the contract would be signed this weekend. Roche’s Chief Executive Severin Schwan said last month that the company was interested in “bolt-on acquisitions”. But a company spokesman declined to confirm the report on Sunday, saying the firm did not comment on rumors.

“We have an open and pragmatic approach to R&D and have mentioned in the past that antibiotics is an area where a lot of interesting science is going on,” Roche spokesman Daniel Grotzky said in an emailed reply to a Reuters enquiry.

Read the full article here:

Re-blogged from